Literature DB >> 29067669

AAV6 Vector Production and Purification for Muscle Gene Therapy.

Christine L Halbert1, James M Allen1, Jeffrey S Chamberlain2.   

Abstract

Vectors derived from adeno-associated viruses (AAV) have been generated using numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are increasingly being used in gene therapy protocols for a variety of human disorders. Methods to produce AAV vectors typically rely on co-transfection of several different plasmid vectors that carry the transgene of interest (the gene to be delivered , in a "transfer plasmid") and helper genes needed for AAV vector replication and packaging (helper plasmids). While the methods used to generate AAV are conceptually simple, minor variations in a variety of steps can result in significant differences in the overall yield of vector. Here we describe protocols for generating vectors derived from AAV6, which are particularly useful for gene transfer to muscle tissues.

Entities:  

Keywords:  AAV; AAV6; AAV9; Adeno-associated viral vector; Duchenne muscular dystrophy; Dystrophin; Gene therapy; Microdystrophin; Systemic delivery

Mesh:

Year:  2018        PMID: 29067669     DOI: 10.1007/978-1-4939-7374-3_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.

Authors:  Laura P van Lieshout; Geoff Soule; Debra Sorensen; Kathy L Frost; Shihua He; Kevin Tierney; David Safronetz; Stephanie A Booth; Gary P Kobinger; Xiangguo Qiu; Sarah K Wootton
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

2.  AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma.

Authors:  Darrick L Yu; Ashley A Stegelmeier; Byram W Bridle; James J Petrik; Sarah K Wootton; Natalie Chow; Amira D Rghei; Kathy Matuszewska; Jack Lawler
Journal:  Cancer Gene Ther       Date:  2019-06-04       Impact factor: 5.987

3.  Incorporation of sensing modalities into de novo designed fluorescence-activating proteins.

Authors:  Lindsey A Doyle; Justin Daho Lee; Jason C Klima; Michael Rappleye; Lauren A Gagnon; Min Yen Lee; Emilia P Barros; Anastassia A Vorobieva; Jiayi Dou; Samantha Bremner; Jacob S Quon; Cameron M Chow; Lauren Carter; David L Mack; Rommie E Amaro; Joshua C Vaughan; Andre Berndt; Barry L Stoddard; David Baker
Journal:  Nat Commun       Date:  2021-02-08       Impact factor: 14.919

4.  CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Authors:  Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

5.  Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model.

Authors:  Niclas E Bengtsson; Julie M Crudele; Jordan M Klaiman; Christine L Halbert; Stephen D Hauschka; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2022-02-08       Impact factor: 12.910

6.  Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model.

Authors:  Zachary M Howard; Lisa E Dorn; Jeovanna Lowe; Megan D Gertzen; Pierce Ciccone; Neha Rastogi; Guy L Odom; Federica Accornero; Jeffrey S Chamberlain; Jill A Rafael-Fortney
Journal:  JCI Insight       Date:  2021-04-08

7.  Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate.

Authors:  Stephen C Kolwicz; John K Hall; Farid Moussavi-Harami; Xiolan Chen; Stephen D Hauschka; Jeffrey S Chamberlain; Michael Regnier; Guy L Odom
Journal:  JACC Basic Transl Sci       Date:  2019-10-02

8.  Development of Novel Micro-dystrophins with Enhanced Functionality.

Authors:  Julian N Ramos; Katrin Hollinger; Niclas E Bengtsson; James M Allen; Stephen D Hauschka; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2019-02-01       Impact factor: 11.454

9.  Gene Transfer in Adeno-Associated Virus Seropositive Rhesus Macaques Following Rapamycin Treatment and Subcutaneous Delivery of AAV6, but Not Retargeted AAV6 Vectors.

Authors:  Daniel Stone; Elizabeth J Kenkel; Michelle A Loprieno; Motoko Tanaka; Harshana S De Silva Feelixge; Arjun J Kumar; Laurence Stensland; Willimark M Obenza; Solomon Wangari; Chul Y Ahrens; Robert D Murnane; Christopher W Peterson; Hans-Peter Kiem; Meei-Li Huang; Martine Aubert; Shiu-Lok Hu; Keith R Jerome
Journal:  Hum Gene Ther       Date:  2020-11-02       Impact factor: 5.695

10.  A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of Mice.

Authors:  Laura P van Lieshout; Jakob M Domm; Tara N Rindler; Kathy L Frost; Debra L Sorensen; Sarah J Medina; Stephanie A Booth; James P Bridges; Sarah K Wootton
Journal:  Mol Ther Methods Clin Dev       Date:  2018-04-14       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.